Abstract
Introduction: Chronic renal failure (CRF) is an irreversible condition, which is indicated by significant reduction in glomerular filtration rate, or irreversible destruction of kidney tissue.1 CRF is characterized by a wide variety of biochemical disturbances and numerous clinical symptoms and signs. Plasma cholesterol levels are usually normal in ureamia but elevated after renal transplantation. In renal failure, these abnormalities of carbohydrate and lipid metabolism presumably contribute to increased risk of atherogenesis, which may be troublesome in patients receiving long-term dialysis.8,9.
Thus the present study was conducted to compare the lipid profile in chronic kidney disease patients on regular hemodialysis and on conservative management
Materials and Methodology: A Hospital based case control study was conducted in Sri Manakula Vinayagar Medical College and Hospital, kalitheerthalkuppam for a period of 6 months, from May/2017 to October/2017. Patients who were diagnosed with Chronic Kidney Disease and admitted into the medical wards were included in the study. Patients with already known diabetes mellitus, ischemic heart disease, patients who had undergone coronary artery bypass graft, on lipid lowering drugs and history of alcohol consumption and smoking were excluded, from the study. Fasting lipid profiles of patients of chronic kidney disease on conservative management (group-I) and on hemodialysis (group-II) were compared.
Results: A total of 80 patients participated in the study. The mean age of the CRF patients was 53.25± 11.04 years. The mean age in our study among the group I participants (40) was 54.41± 10.86 years and in group II (40) it was found to be 51.87 ± 11.23 years. This study showed that total cholesterol, triglycerides, HDL, LDL, VLDL were significantly lower in the CRF patients on regular hemodialysis (p<0.05). Total cholesterol, triglycerides and VLDL were significantly higher among female gender with p value <0.05
Conclusion: Chronic kidney disease, due to its alteration in carbohydrate and lipid metabolism can lead on to increased atherogenesis and contribute to mortality. This necessitates the periodic monitoring and maintenance of lipid profiles within recommended range in CKD patients not on hemodialysis also.
References
- Dewardener, H.E. An outline of normal and abnormal function. In: The kidney 4th edition Churchill Livingstone New York.1986; 181-235.
- Mathenge R.N, Mcligego, S.O., Mutua, A.K. and Otieno, L.S The spectrum of echocardiographic finding in chronic renal failure. East African Medical Journal ,2003;70(3): 97-103.
- Moronkola O.A, Ojediran M.M, and Amosu A. Menstrual disorder in chronic renal failure patients attending renal clinics in Ibadan, Nigeria. African Health Sciences, 2006; 6 (3): 155-160.
- Riepponen P, Maniemit J, and Flanwlya, A.C. Immunoturbidimetric determination of apolipoprotein A1 and B in serum. Journal of Clinical Laboratory Investigation, 1987; 47: 739-744.
- Ekonoyan G. The epidemic of cardiovascular disease in patients with chronic renal disease. American Journal of Kidney Disease, 1998; 32: 3-5.
- Gomez DI, Giammonioa AM, Touceda LA,. Variation in the lipid profile of patients with chronic renal failure with folic acid. International Journal of Vitamin Nutritional Resources, 2003; 73: 215-220.
- Jay HS, John E, Peter OK, and Nicholas F.I.. Renal and electrolyte disorder. In: Internal Medicine. 5th edition. Mosby Incorporated New York., 1988;738-990.
- Ahman, P.O, Samuelson D and Alaupevic, P,. Lipoprotein metabolism and renal failure. American journal of Nephrology, 1998; 4: 547-553.
- Markell Ms, Arimenti, RA, Donavitin G and Sumrani, W. Hyperlipidaemia and glucose intolerance in post renal transplant patient. Journal of American Society of Nephrology, 2004; 163: 202-223.
- Adejumo OA, Okaka EI, Ojogwu LI. Lipid profile in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana medical journal. 2016;50(1):44-9.
- Kumari KR, Srinivas B. Study of Lipid Profile in Patients with Chronic Kidney Disease on Conservative Management and Hemodialysis.
- Baria D, Joshi V, Shah T, Gandha K, Modi N. Impact of Hemodialysis on Lipid Profile among Chronic Renal Failure Patients - A Case Control Study. International Journal of Scientific and Research Publications 2013;3(7)
- Moradi H, Vaziri ND. Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.
- Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Gezer M, Taş A, Eyileten T, Guler AK, Aydin İ. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival. European journal of internal medicine. 2016 Sep 1;33:81-7.
- Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. The American journal of cardiology. 2000 Dec 21;86(12):19-22.
- Nitta K. Clinical assessment and management of dyslipidemia in patients with chronic kidney disease. Clinical and experimental nephrology. 2012 Aug 1;16(4):522-9.
Corresponding Author
Dr Girija .S
Associate Professor, Department of General Medicine, SMVMCH, Kalitheerthalakuppam, Puducherry 605107, India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v7i3.220
